Clinical Trial

Sensei Biotherapeutics Announces Initiation of Combination Arm for Phase 1/2 Clinical Study of SNS-101 with Regeneron’s Libtayo®

- Eleven patients enrolled overall in trial to date, with enrollment progressing faster than anticipated - - Monotherapy arm has…

1 year ago

ZyVersa Therapeutics’ CEO, Stephen C. Glover to Participate in Panel at the BioFlorida Conference Discussing Inflammation and its Impact on Numerous Diseases

Mr. Glover will also serve as a judge in BioPitch competition for life science companies seeking seed and early-stage investment.ZyVersa…

1 year ago

Matinas BioPharma to Feature MAT2203 in a Pipeline Presentation at IDWeek

BEDMINSTER, N.J., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Matinas BioPharma (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on redefining…

1 year ago

Skye Bioscience Receives Clinical Site Approvals for Glaucoma Phase 2a Trial

Patient enrollment starting in Q4 2023 for proof-of-concept P2a study of CB1 agonist Phase 1 study complete and data will…

1 year ago

Cytel continues expansion of market access and medical communication capabilities with the acquisition of co.faktor

WALTHAM, Mass.--(BUSINESS WIRE)--Cytel Inc., provider of quantitative insights and health data analytics to leaders in the life sciences, has acquired…

1 year ago

Neuromuscular Electrical Stimulation as a Treatment for Obstructive Sleep Apnea Gains Traction With a Recently Announced World Sleep 2023 Congress Symposium

BOSTON & LONDON--(BUSINESS WIRE)--Signifier Medical Technologies LLC (“Signifier” or the “Company”), a Boston- and London-based medical technology company, is excited…

1 year ago

COTA Announces New Data Platform to Accelerate Cancer Research and Advance Generative AI Models for Cancer Care

Vista will set the standard for automating the abstraction of oncology data critical to accelerate research and build trust in…

1 year ago

Napo Pharmaceuticals Supports Groundbreaking Study on Quality of Life for Cancer Patients and Survivors

SAN FRANCISCO, CA / ACCESSWIRE / September 26, 2023 / In an effort to shed light on the diverse and…

1 year ago

Lumos Pharma Announces New Data and Analysis of 15 Subjects from OraGrowtH212 Trial Presented at the 2023 ESPE Annual Meeting

Deconvolution Analysis Shows 60% Increase in GH Secretion, Comparable to Established Values in Normal Children Analysis Shows Annualized Height Velocity…

1 year ago

IR-MED to Conduct Usability Study with Methodist Healthcare of San Antonio for its PressureSafe Device Which is Slated for U.S. Launch in H1 2024

IR-Med, Inc. Figure 1PressureSafe, a skin color agnostic decision support device, for the early detection of pressure injuriesStudy to address…

1 year ago